Fetal mechanisms in neurodevelopmental disorders.

Minding the calcium store: Ryanodine receptor activation as a convergent mechanism of PCB toxicity. Pharmacol Ther (2009) 1.63

High pregnancy anxiety during mid-gestation is associated with decreased gray matter density in 6-9-year-old children. Psychoneuroendocrinology (2010) 1.45

Developmental exposure to polychlorinated biphenyls interferes with experience-dependent dendritic plasticity and ryanodine receptor expression in weanling rats. Environ Health Perspect (2008) 1.27

Neurobehavioral and neurodevelopmental effects of pesticide exposures. Neurotoxicology (2012) 1.25

Maternal pregnancy-specific anxiety is associated with child executive function at 6-9 years age. Stress (2011) 1.15

Application of a mathematical model to describe the effects of chlorpyrifos on Caenorhabditis elegans development. PLoS One (2009) 1.14

Dynamic gene and protein expression patterns of the autism-associated met receptor tyrosine kinase in the developing mouse forebrain. J Comp Neurol (2009) 1.13

Mechanisms of lead and manganese neurotoxicity. Toxicol Res (Camb) (2013) 1.09

Maturation of the human fetal startle response: evidence for sex-specific maturation of the human fetus. Early Hum Dev (2009) 1.05

CENTS: cortical enhanced neonatal tissue segmentation. Hum Brain Mapp (2011) 1.03

Implications of prenatal steroid perturbations for neurodevelopment, behavior, and autism. Endocr Rev (2014) 0.97

Infant siblings and the investigation of autism risk factors. J Neurodev Disord (2012) 0.94

Opinion: Sex, Gender and the Diagnosis of Autism - A Biosocial View of the Male Preponderance. Res Autism Spectr Disord (2013) 0.93

Drugs, biogenic amine targets and the developing brain. Dev Neurosci (2009) 0.90

Prenatal betamethasone exposure has sex specific effects in reversal learning and attention in juvenile baboons. Am J Obstet Gynecol (2011) 0.86

Characterizing exposures and neurobehavioral performance in Egyptian adolescent pesticide applicators. Metab Brain Dis (2014) 0.86

The Role of Stress in Brain Development: The Gestational Environment's Long-Term Effects on the Brain. Cerebrum (2012) 0.85

The fatty acid oxidation product 15-A3t-isoprostane is a potent inhibitor of NFκB transcription and macrophage transformation. J Neurochem (2011) 0.84

Neurobehavioral manifestations of developmental impairment of the brain. Interdiscip Toxicol (2010) 0.82

Transcriptional responses of cultured rat sympathetic neurons during BMP-7-induced dendritic growth. PLoS One (2011) 0.80

Brain Tissue Segmentation of Neonatal MR Images Using a Longitudinal Subject-specific Probabilistic Atlas. Proc SPIE Int Soc Opt Eng (2009) 0.80

Neuronal Nuclear Membrane Budding Occurs during a Developmental Window Modulated by Torsin Paralogs. Cell Rep (2016) 0.79

On the protective effect of omega-3 against propionic acid-induced neurotoxicity in rat pups. Lipids Health Dis (2011) 0.79

Delayed effects of developmental exposure to low levels of the aryl hydrocarbon receptor agonist 3,3',4,4',5-pentachlorobiphenyl (PCB126) on adult zebrafish behavior. Neurotoxicology (2015) 0.77

Inducing dendritic growth in cultured sympathetic neurons. J Vis Exp (2012) 0.77

Neuroimaging endophenotypes in autism spectrum disorder. CNS Spectr (2015) 0.76

Developmental neurotoxicity of succeeding generations of insecticides. Environ Int (2016) 0.75

The risk of schizophrenia and child psychiatric disorders in offspring of mothers with lung cancer and other types of cancer: a Danish nationwide register study. PLoS One (2013) 0.75

Fetal origins of autism spectrum disorders: the non-associated maternal factors. Future Sci OA (2016) 0.75

A 10-month prospective study of organophosphorus pesticide exposure and neurobehavioral performance among adolescents in Egypt. Cortex (2015) 0.75

Cortical Enhanced Tissue Segmentation of Neonatal Brain MR Images Acquired by a Dedicated Phased Array Coil. Proc IEEE Comput Soc Conf Comput Vis Pattern Recognit (2009) 0.75

Emerging various environmental threats to brain and overview of surveillance system with zebrafish model. Toxicol Rep (2017) 0.75

Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol (2007) 6.96

Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol (2005) 5.95

Multiple serotonergic brainstem abnormalities in sudden infant death syndrome. JAMA (2006) 5.10

Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci (2002) 4.36

A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci U S A (2006) 3.55

In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes. Am J Obstet Gynecol (2009) 3.41

Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet (2008) 3.41

A transient placental source of serotonin for the fetal forebrain. Nature (2011) 2.71

Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nat Neurosci (2007) 2.70

Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol (2003) 2.65

The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci (2011) 2.61

Brainstem serotonergic deficiency in sudden infant death syndrome. JAMA (2010) 2.55

Developmental regression and mitochondrial dysfunction in a child with autism. J Child Neurol (2006) 2.49

Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics (2010) 2.45

Disconnection of the ascending arousal system in traumatic coma. J Neuropathol Exp Neurol (2013) 2.38

Sensory and motor deficits in children with cerebral palsy born preterm correlate with diffusion tensor imaging abnormalities in thalamocortical pathways. Dev Med Child Neurol (2009) 2.34

Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nat Rev Neurosci (2009) 2.33

Developmental exposure to chlorpyrifos elicits sex-selective alterations of serotonergic synaptic function in adulthood: critical periods and regional selectivity for effects on the serotonin transporter, receptor subtypes, and cell signaling. Environ Health Perspect (2004) 2.25

Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry (2005) 2.19

Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J Neurosci (2003) 2.18

Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5). JAMA Pediatr (2013) 2.18

Fetal programming of hypothalamo-pituitary-adrenal function: prenatal stress and glucocorticoids. J Physiol (2006) 2.18

Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry (2007) 2.12

Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol (2007) 2.02

How the timing and quality of early experiences influence the development of brain architecture. Child Dev (2010) 1.87

Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol (2008) 1.87

Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci (2002) 1.79

Developmental exposure of rats to chlorpyrifos leads to behavioral alterations in adulthood, involving serotonergic mechanisms and resembling animal models of depression. Environ Health Perspect (2005) 1.79

PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. J Neurochem (2004) 1.76

Early experience modifies the postnatal assembly of autonomic emotional motor circuits in rats. J Neurosci (2005) 1.76

Interferon-gamma expression in periventricular leukomalacia in the human brain. Brain Pathol (2004) 1.75

Gray matter injury associated with periventricular leukomalacia in the premature infant. Acta Neuropathol (2007) 1.74

The organization of the transcriptional network in specific neuronal classes. Mol Syst Biol (2009) 1.74

Brain anomalies in children exposed prenatally to a common organophosphate pesticide. Proc Natl Acad Sci U S A (2012) 1.72

Prenatal chlorpyrifos exposure in rats causes persistent behavioral alterations. Neurotoxicol Teratol (2002) 1.72

The Human Connectome Project and beyond: initial applications of 300 mT/m gradients. Neuroimage (2013) 1.70

Maternal tobacco smoking, nicotine replacement and neurobehavioural development. Acta Paediatr (2008) 1.70

Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet (2002) 1.68

Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis. Mol Cell Biol (2003) 1.68

Failed heart rate recovery at a critical age in 5-HT-deficient mice exposed to episodic anoxia: implications for SIDS. J Appl Physiol (1985) (2011) 1.67

Critical appraisal of DNA microarrays in psychiatric genomics. Biol Psychiatry (2006) 1.66

Valproic acid prevents brain injury in a canine model of hypothermic circulatory arrest: a promising new approach to neuroprotection during cardiac surgery. Ann Thorac Surg (2006) 1.64

Is the PentaBDE replacement, tris (1,3-dichloro-2-propyl) phosphate (TDCPP), a developmental neurotoxicant? Studies in PC12 cells. Toxicol Appl Pharmacol (2011) 1.63

Fetal chlorpyrifos exposure: adverse effects on brain cell development and cholinergic biomarkers emerge postnatally and continue into adolescence and adulthood. Environ Health Perspect (2003) 1.62

Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Res (2008) 1.61

Integration of neuronal clones in the radial cortical columns by EphA and ephrin-A signalling. Nature (2009) 1.59

Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury. Pediatr Crit Care Med (2007) 1.59

RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Nat Neurosci (2006) 1.58

Adolescent vs. adult-onset nicotine self-administration in male rats: duration of effect and differential nicotinic receptor correlates. Neurotoxicol Teratol (2007) 1.56

Risk factors for sudden infant death syndrome among northern plains Indians. JAMA (2002) 1.56

Gastrointestinal dysfunction in autism: parental report, clinical evaluation, and associated factors. Autism Res (2012) 1.55

Gender-specific effects of prenatal and adolescent exposure to tobacco smoke on auditory and visual attention. Neuropsychopharmacology (2007) 1.54

Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker fractin. Pediatr Res (2008) 1.53

Alterations in central nervous system serotonergic and dopaminergic synaptic activity in adulthood after prenatal or neonatal chlorpyrifos exposure. Environ Health Perspect (2005) 1.53

Maternal dietary tryptophan deficiency alters cardiorespiratory control in rat pups. J Appl Physiol (1985) (2010) 1.51

Development of microglia in the cerebral white matter of the human fetus and infant. J Comp Neurol (2006) 1.49

The developing oligodendrocyte: key cellular target in brain injury in the premature infant. Int J Dev Neurosci (2011) 1.46

Plasma serotonin in autism. Pediatr Neurol (2006) 1.46

Dissociation of corticothalamic and thalamocortical axon targeting by an EphA7-mediated mechanism. Neuron (2005) 1.44

Serotonergic systems targeted by developmental exposure to chlorpyrifos: effects during different critical periods. Environ Health Perspect (2003) 1.44

Oxidative mechanisms contributing to the developmental neurotoxicity of nicotine and chlorpyrifos. Toxicol Appl Pharmacol (2004) 1.43

Arrested oligodendrocyte lineage progression during human cerebral white matter development: dissociation between the timing of progenitor differentiation and myelinogenesis. J Neuropathol Exp Neurol (2002) 1.42

Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp Neurol (2004) 1.42

Axonal development in the cerebral white matter of the human fetus and infant. J Comp Neurol (2005) 1.42

Developmental neurotoxicity of chlorpyrifos: what is the vulnerable period? Environ Health Perspect (2002) 1.41

Pharmacological preconditioning ameliorates neurological injury in a model of spinal cord ischemia. Ann Thorac Surg (2002) 1.41

Trust evaluation in health information on the World Wide Web. Conf Proc IEEE Eng Med Biol Soc (2008) 1.40

Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: A pregnant dam mouse model. J Neuroimmunol (2009) 1.40

Neuroanatomic connectivity of the human ascending arousal system critical to consciousness and its disorders. J Neuropathol Exp Neurol (2012) 1.38

Chlorpyrifos affects phenotypic outcomes in a model of mammalian neurodevelopment: critical stages targeting differentiation in PC12 cells. Environ Health Perspect (2006) 1.37

Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics (2009) 1.37

Glucocorticoids and sex-dependent development of brain glucocorticoid and mineralocorticoid receptors. Endocrinology (2003) 1.36

Risk factor changes for sudden infant death syndrome after initiation of Back-to-Sleep campaign. Pediatrics (2012) 1.36

Persistent cognitive alterations in rats after early postnatal exposure to low doses of the organophosphate pesticide, diazinon. Neurotoxicol Teratol (2007) 1.36

Amygdala gene expression correlates of social behavior in monkeys experiencing maternal separation. J Neurosci (2007) 1.35

Hypoxic-ischemic encephalopathy in the term infant. Clin Perinatol (2009) 1.35

Nicotine is a developmental neurotoxicant and neuroprotectant: stage-selective inhibition of DNA synthesis coincident with shielding from effects of chlorpyrifos. Brain Res Dev Brain Res (2003) 1.34

Retracted Maternal adversity, glucocorticoids and programming of neuroendocrine function and behaviour. Neurosci Biobehav Rev (2005) 1.32

Developmental diazinon neurotoxicity in rats: later effects on emotional response. Brain Res Bull (2007) 1.32

Single-neuron RNA-Seq: technical feasibility and reproducibility. Front Genet (2012) 1.32

Antibrain antibodies in children with autism and their unaffected siblings. J Neuroimmunol (2006) 1.30

Autism-associated promoter variant in MET impacts functional and structural brain networks. Neuron (2012) 1.29

Behavioral alterations in adolescent and adult rats caused by a brief subtoxic exposure to chlorpyrifos during neurulation. Neurotoxicol Teratol (2004) 1.27

Persistent behavioral alterations in rats neonatally exposed to low doses of the organophosphate pesticide, parathion. Brain Res Bull (2008) 1.26

Short periods of prenatal stress affect growth, behaviour and hypothalamo-pituitary-adrenal axis activity in male guinea pig offspring. J Physiol (2005) 1.26

Critical review: nicotine for the fetus, the infant and the adolescent? J Health Psychol (2007) 1.26

Mode of action: disruption of brain cell replication, second messenger, and neurotransmitter systems during development leading to cognitive dysfunction--developmental neurotoxicity of nicotine. Crit Rev Toxicol (2006) 1.25

RGS4 is a negative regulator of insulin release from pancreatic beta-cells in vitro and in vivo. Proc Natl Acad Sci U S A (2010) 1.25

Quantitative morphological assessment reveals neuronal and glial deficits in hippocampus after a brief subtoxic exposure to chlorpyrifos in neonatal rats. Brain Res Dev Brain Res (2005) 1.24

Antibodies against fetal brain in sera of mothers with autistic children. J Neuroimmunol (2008) 1.24

Metabolic maturation of the human brain from birth through adolescence: insights from in vivo magnetic resonance spectroscopy. Cereb Cortex (2012) 1.23

Circuit-specific intracortical hyperconnectivity in mice with deletion of the autism-associated Met receptor tyrosine kinase. J Neurosci (2011) 1.22

Fetal programming of hypothalamic-pituitary-adrenal (HPA) axis function and behavior by synthetic glucocorticoids. Brain Res Rev (2007) 1.22

The late preterm infant and the control of breathing, sleep, and brainstem development: a review. Clin Perinatol (2006) 1.21

Developmental effects of chlorpyrifos extend beyond neurotoxicity: critical periods for immediate and delayed-onset effects on cardiac and hepatic cell signaling. Environ Health Perspect (2004) 1.20

NIH Consensus Development Conference statement: inhaled nitric-oxide therapy for premature infants. Pediatrics (2011) 1.20

Prenatal nicotine exposure alters the response to nicotine administration in adolescence: effects on cholinergic systems during exposure and withdrawal. Neuropsychopharmacology (2004) 1.19

Nonenzymatic functions of acetylcholinesterase splice variants in the developmental neurotoxicity of organophosphates: chlorpyrifos, chlorpyrifos oxon, and diazinon. Environ Health Perspect (2007) 1.18

Silver impairs neurodevelopment: studies in PC12 cells. Environ Health Perspect (2010) 1.18

Thalamic damage in periventricular leukomalacia: novel pathologic observations relevant to cognitive deficits in survivors of prematurity. Pediatr Res (2009) 1.18